Dow Jones Top Company Headlines at 3 am ET: OpenAI Scraps Release of New AI Model over Safety Concerns | Novo ...

Dow Jones
09/29

OpenAI Scraps Release of New AI Model Over Safety Concerns

The model, dubbed GPT-6.1 Astra, was due to debut inside ChatGPT and Codex in October.

----

Novo Inks Weight-Loss Licensing Deal With Hengrui Pharma

The Danish drugmaker signed a licensing deal for a weight-loss treatment being developed by Hengrui Pharma that could be worth up to $2.6 billion.

----

Hapag-Lloyd Raises Guidance Again on Strong Demand, Freight Rates

It cautioned, however, that freight rates are volatile and that the outlook is subject to a high degree of uncertainty given current and persistent geopolitical challenges.

----

Shein's Earnings Disappoint, Sending Stock Lower

The fast-fashion retailer's rocky start as a publicly listed continued as its first earnings since listing disappointed, sending its Hong Kong-listed stock down to a record low.

----

Google Appeals EU Requests on Android AI Access, Search Data Sharing

Google said it has filed appeals with the European Union's second-highest court against binding instructions to open up its Android operating system, allow other search engines to access search data.

----

Samsung Commits $1.0 Billion to AI Infrastructure Firm Backed by KKR, Nvidia

The investment in Helix Digital Infrastructure brings the platform's total secured capital to more than $11 billion.

----

Anthropic's potential $2 trillion IPO comes with the following fine print

Anthropic's revenue grew over 10-fold in 2025, but the cost of training and serving its models is also climbing.

----

Goldman's Board Has Discussed a Plan to Name John Waldron as Its Next CEO

Under the plan, David Solomon, who has led the bank since 2018, would step down as soon as next year and be executive chair.

----

AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs

Summit shares surged in after-hours trading following the news of AstraZeneca's investment, as the two companies plan to ramp up their collaboration on developing cancer treatments.

----

Raytheon Gets $20.7 Billion Contract to Accelerate AMRAAM Missile Production

Under the five-year contract, with two option years, Raytheon said it will scale AMRAAM missile production to record levels to meet long-term demand.

----

AMD to Acquire World Labs for $8.2 Billion

The semiconductor company said the deal would help it develop better hardware, software and systems, especially in the growing field of physical AI and robotics.

----

Jefferies Stock Falls Despite Earnings Beat and Record Banking Revenue

Jefferies Financial Group reported a 16% increase in quarterly profit, but its shares slipped after hours.

----

FAA to Delay 737 MAX 10 Approval Over New Software Glitch

Air-safety regulators will assess a possible safety risk before certifying the longest and final model of Boeing's bestselling jet.

----

AAR to Pay $1.8 Billion for Stake in Aircraft-Maintenance Company

The aviation-services supplier agreed to buy a majority stake in the Bain-backed MRO Holdings.

----

The Nike Lifer Driving a High-Stakes Turnaround in China

Once one of its best markets, the country is now a major cause of the sportswear giant's sinking fortunes.

----

Meta Seeks Payoff From AI Spending With New Push for Business Customers

The tech giant is pushing to monetize its multibillion-dollar AI investments by selling more tools and services to companies.

----

SpaceX Launches Starship for First Orbital Mission

Starship entered orbit for the first time and deployed the latest version of Starlink satellites, critical steps in the company's push for the experimental rocket to handle a range of missions.

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10